A new family of angiogenic factors
- 18 May 2006
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 236 (2) , 157-163
- https://doi.org/10.1016/j.canlet.2005.04.008
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Development of Molecular Targeted Anticancer Agents: Successes, Failures and Future DirectionsCurrent Pharmaceutical Design, 2005
- Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functionsExperimental & Molecular Medicine, 2004
- A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal CancerNew England Journal of Medicine, 2003
- Angiogenesis in health and diseaseNature Medicine, 2003
- The therapeutic potential of novel antiangiogenic therapiesExpert Opinion on Investigational Drugs, 2003
- Alternative splicing of the proadrenomedullin gene results in differential expression of gene productsJournal of Molecular Endocrinology, 2001
- Hypoxia-Inducible Factor-1 (HIF-1) Up-Regulates Adrenomedullin Expression in Human Tumor Cell Lines during Oxygen Deprivation: A Possible Promotion Mechanism of CarcinogenesisMolecular Endocrinology, 2000
- Molecular Mechanisms of Tumor Angiogenesis and Tumor ProgressionJournal of Neuro-Oncology, 2000
- Genomic Structure of Human Adrenomedullin GeneBiochemical and Biophysical Research Communications, 1994
- Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human PheochromocytomaBiochemical and Biophysical Research Communications, 1993